Subscribe
Magazine
Videos
Advertise
About Us
Smart Water Summit
Wastewater Summit
Drinking Water
Smart Water
Asset Management
Water Utility Management
Water Reuse
Global Thought Leaders
Podcast
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
WaterWorld Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Sensorion
< Previous
1
2
3
Next >
Sensorion Announces Approval to Initiate Lead Gene Therapy Candidate SENS-501 (OTOF-GT) into a Phase 1/2 Clinical Trial in some European Countries
January 19, 2024
From
Sensorion
Via
Business Wire
Sensorion Announces Partnership With the Institut Pasteur to Accelerate Gene Therapy Programs Targeting Hearing Disorders Has Been Extended for Five Years
January 05, 2024
From
Sensorion
Via
Business Wire
Sensorion Publishes Results of Combined General Meeting Resolutions
December 21, 2023
From
Sensorion
Via
Business Wire
Sensorion Provides an Update on NOTOXIS, its Proof of Concept Phase 2a Clinical Trial of SENS-401 in Cisplatin-Induced Ototoxicity (CIO)
December 18, 2023
From
Sensorion
Via
Business Wire
Sensorion Appoints CMC Expert Bernd Schmidt as New Chief Technical Officer
December 12, 2023
From
Sensorion
Via
Business Wire
Sensorion Provides Preliminary Documents for the Combined Shareholders’ General Meeting of December 20, 2023
November 30, 2023
From
Sensorion
Via
Business Wire
Sensorion Announces Its Attendance at the 42nd Annual J.P. Morgan Healthcare Meeting in San Francisco
November 23, 2023
From
Sensorion
Via
Business Wire
Sensorion to Participate in the Jefferies London Healthcare Conference and McDermott Will & Emery’s Life Sciences Symposium
October 25, 2023
From
Sensorion
Via
Business Wire
Sensorion Will Present At The European Society Of Gene & Cell Therapy (ESGCT) Conference
October 18, 2023
From
Sensorion
Via
Business Wire
Sensorion Announces the Availability of Its Financial Report for the 1st Half of 2023
September 26, 2023
From
Sensorion
Via
Business Wire
Sensorion Announces Webconference on September 25, 2023, and its Participation in Upcoming Investor Conferences in October 2023
September 21, 2023
From
Sensorion
Via
Business Wire
Sensorion Reports 2023 First Half Results
September 20, 2023
From
Sensorion
Via
Business Wire
Sensorion Submits Clinical Trial Application for OTOF-GT, its Lead Gene Therapy Candidate, in Europe
July 19, 2023
From
Sensorion
Via
Business Wire
Sensorion Submits Clinical Trial Application for Lead Gene Therapy Candidate OTOF-GT in the UK
July 10, 2023
From
Sensorion
Via
Business Wire
Sensorion Reports Positive Efficacy Data from SENS-401 Phase 2a Clinical Study
July 05, 2023
From
Sensorion
Via
Business Wire
Sensorion Reports Promising Preliminary Data from SENS-401 Phase 2a Clinical Study
June 19, 2023
From
Sensorion
Via
Business Wire
Sensorion to Host Key Opinion Leader Webinar on July 5, 2023; Confirms Upcoming Key Milestones
June 07, 2023
From
Sensorion
Via
Business Wire
Sensorion Publishes Results of Combined Shareholders’ General Meeting Resolutions
May 25, 2023
From
Sensorion
Via
Business Wire
Sensorion Will Present Two Posters At The American Society Of Cell And Gene Therapy (ASGCT) 26th Annual Meeting
May 11, 2023
From
Sensorion
Via
Business Wire
Sensorion Provides Preliminary Documents for the Combined Shareholders’ General Meeting of May 24, 2023
May 03, 2023
From
Sensorion
Via
Business Wire
Sensorion to Host a Symposium during ISIET’s International Symposium on Inner Ear Therapeutics on April 30, 2023
April 24, 2023
From
Sensorion
Via
Business Wire
Sensorion to participate in Chardan’s Annual Genetic Medicines & Cell Therapy Manufacturing Summit and Kempen’s Life Sciences Conference
April 18, 2023
From
Sensorion
Via
Business Wire
Sensorion Announces Candidate Selection for GJB2 Gene Therapy Program
April 06, 2023
From
Sensorion
Via
Business Wire
Sensorion Appoints Khalil Barrage as Interim Chairman of the Board
March 31, 2023
From
Sensorion
Via
Business Wire
Sensorion Announces the Publication of Its 2022 Annual Financial Report
March 30, 2023
From
Sensorion
Via
Business Wire
Sensorion Reports Full-Year 2022 Financial Results and Business Update
March 16, 2023
From
Sensorion
Via
Business Wire
Sensorion Announces Agenda For R&D Day Showcasing Gene Therapy For Inner Ear Disease
March 14, 2023
From
Sensorion
Via
Business Wire
Sensorion Discloses No Exposure To Silicon Valley Bank Closure
March 13, 2023
From
Sensorion
Via
Business Wire
Sensorion to Participate in the 6th Annual Bioprocessing Summit Europe
March 07, 2023
From
Sensorion
Via
Business Wire
Sensorion Further Strengthens Leadership, Appoints David Lawrence as Chief Financial Officer
February 27, 2023
From
Sensorion
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.